Current financial headlines
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
MT Newswires Deals and strategy
Chronological news
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
H. Lundbeck (CPSE:HLUN B) has just secured Japanese marketing authorization for eptinezumab in migraine prevention, a fresh regulatory milestone that broadens its neuroscience footprint and adds another data point for investors watching the stock. The eptinezumab approval lands at a time when H. Lundbeck's โฆ
Sharemaestro market context Trend signal active 52 weeks -1.8%Search by ticker symbol or company name and select a result to open its chart.
Start typing to find a stock or ETF.
Choose one or more countries for market search, or include every covered market.
Currently searching United States